4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow this drug Literature Review of pexiganan trials Research Report on pexiganan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers Topical pexiganan cream 0.8%, Topical placebo cream, Standard wound care - Diabetic Foot Infection | Phase 3 | Completed | Dipexium Pharmaceuticals, Inc. | 189 | 2014-06-01 | 2017-06-14 |
| Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers Topical pexiganan cream 0.8%, Topical placebo cream, Standard wound care - Diabetic Foot Infection | Phase 3 | Completed | Dipexium Pharmaceuticals, Inc. | 200 | 2014-06-01 | 2017-06-14 |
| MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers ofloxacin, MSI-78 - Diabetic Foot Ulcers | Phase 3 | Completed | Abeona Therapeutics, Inc | 584 | 1994-08-01 | 2020-09-03 |
| MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers ofloxacin, MSI-78 - Diabetic Foot Ulcers | Phase 3 | Completed | Abeona Therapeutics, Inc | 342 | 1994-08-01 | 2020-09-03 |
Diabetes Mellitus (2) · Diabetic Foot (2) · Ulcer (2)
Abeona Therapeutics, Inc (2) · Dipexium Pharmaceuticals, Inc. (2)
United States (4)
Michael H. Silverman, MD (2) · Paul Litka, MD (2)